Multiple Sclerosis News Today Forums › Forums › Trials and Research › Switching from Gilenya to Rituximab for MS May Be Problem, Case Study Says

  • Trials and Research

    Switching from Gilenya to Rituximab for MS May Be Problem, Case Study Says

    Posted by MS News Today Moderator on August 30, 2018 at 5:50 pm

    Autoimmune diseases such as MS have too many B-cells or overactive B-cells, so rituximab may help rid the body of the excess immune cells.

    Discontinuing Gilenya (fingolimod) treatment and starting on rituximab therapy may be more complicated than originally thought. A new report chronicles the medical journey of a man with multiple sclerosis (MS) treated with these drugs, and proposes a new treatment regimen.

    Read more about it here.

    What do you think about this news?

    replied 5 years, 8 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .